{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:56Z","timestamp":1787020916438,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"BBRSC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heme and iron homeostasis is perturbed in Alzheimer\u2019s disease (AD); therefore, the aim of the study was to examine the levels and association of heme with iron-binding plasma proteins in cognitively normal (CN), mild cognitive impairment (MCI), and AD individuals from the Australian Imaging, Biomarker and Lifestyle Flagship Study of Ageing (AIBL) and Kerr Anglican Retirement Village Initiative in Ageing Health (KARVIAH) cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Non-targeted proteomic analysis by high-resolution mass spectrometry was performed to quantify relative protein abundances in plasma samples from 144 CN individuals from the AIBL and 94 CN from KARVIAH cohorts and 21 MCI and 25\u2009AD from AIBL cohort. ANCOVA models were utilized to assess the differences in plasma proteins implicated in heme\/iron metabolism, while multiple regression modeling (and partial correlation) was performed to examine the association between heme and iron proteins, structural neuroimaging, and cognitive measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the plasma proteins implicated in iron and heme metabolism, hemoglobin subunit \u03b2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) was significantly increased in AD compared to CN individuals. Multiple regression modeling adjusted for age, sex, APOE\u03b54 genotype, and disease status in the AIBL cohort revealed lower levels of transferrin but higher levels of hemopexin associated with augmented brain amyloid deposition. Meanwhile, transferrin was positively associated with hippocampal volume and MMSE performance, and hemopexin was negatively associated with CDR scores. Partial correlation analysis revealed lack of significant associations between heme\/iron proteins in the CN individuals progressing to cognitive impairment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In conclusion, heme and iron dyshomeostasis appears to be a feature of AD. The causal relationship between heme\/iron metabolism and AD warrants further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-020-00634-1","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T11:03:39Z","timestamp":1591700619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Plasma transferrin and hemopexin are associated with altered A\u03b2 uptake and cognitive decline in Alzheimer\u2019s disease pathology"],"prefix":"10.1186","volume":"12","author":[{"given":"Azhaar","family":"Ashraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratishtha","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Goozee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaikai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Fripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Villemagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Hye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph N.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3449-8532","authenticated-orcid":false,"given":"Po-Wah","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AIBL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"issue":"5","key":"634_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/alzrt143","volume":"4","author":"M Wortmann","year":"2012","unstructured":"Wortmann M. Dementia: a global health priority - highlights from an ADI and World Health Organization report. Alzheimers Res Ther. 2012;4(5):40.","journal-title":"Alzheimers Res Ther"},{"issue":"10043","key":"634_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM. Alzheimer\u2019s disease. Lancet. 2016;388(10043):505\u201317.","journal-title":"Lancet"},{"issue":"6","key":"634_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8(6):595\u2013608.","journal-title":"EMBO Mol Med"},{"issue":"11","key":"634_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1212\/01.wnl.0000344568.09360.31","volume":"72","author":"WJ Henneman","year":"2009","unstructured":"Henneman WJ, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, Scheltens P, Vrenken H, Barkhof F. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology. 2009;72(11):999\u20131007.","journal-title":"Neurology"},{"issue":"3","key":"634_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1212\/WNL.0b013e318225aaa9","volume":"77","author":"RC Shah","year":"2011","unstructured":"Shah RC, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis. Neurology. 2011;77(3):219\u201326.","journal-title":"Neurology"},{"issue":"1","key":"634_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000170905","volume":"32","author":"RC Shah","year":"2009","unstructured":"Shah RC, Wilson RS, Tang Y, Dong X, Murray A, Bennett DA. Relation of hemoglobin to level of cognitive function in older persons. Neuroepidemiology. 2009;32(1):40\u20136.","journal-title":"Neuroepidemiology"},{"issue":"11","key":"634_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/mp.2013.178","volume":"19","author":"NG Faux","year":"2014","unstructured":"Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, et al. An anemia of Alzheimer\u2019s disease. Mol Psychiatry. 2014;19(11):1227\u201334.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"634_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1021\/cn5003557","volume":"6","author":"DJ Hare","year":"2015","unstructured":"Hare DJ, Doecke JD, Faux NG, Rembach A, Volitakis I, Fowler CJ, Grimm R, Doble PA, Cherny RA, Masters CL, et al. Decreased plasma iron in Alzheimer\u2019s disease is due to transferrin desaturation. ACS Chem Neurosci. 2015;6(3):398\u2013402.","journal-title":"ACS Chem Neurosci"},{"key":"634_CR9","doi-asserted-by":"crossref","unstructured":"Ashraf A, Stosnach H, Parkes HG, Hye A, Powell J, So PW, AddNeuroMed c: Pattern of altered plasma elemental phosphorus, calcium, zinc, and iron in Alzheimer\u2019s disease. Sci Rep 2019, 9(1):3147.","DOI":"10.1038\/s41598-019-42217-7"},{"key":"634_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fnagi.2018.00065","volume":"10","author":"A Ashraf","year":"2018","unstructured":"Ashraf A, Clark M, So PW. The aging of iron man. Front Aging Neurosci. 2018;10:65.","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"634_CR11","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/mp.2017.146","volume":"23","author":"K Goozee","year":"2018","unstructured":"Goozee K, Chatterjee P, James I, Shen K, Sohrabi HR, Asih PR, Dave P, ManYan C, Taddei K, Ayton SJ, et al. Elevated plasma ferritin in elderly individuals with high neocortical amyloid-beta load. Mol Psychiatry. 2018;23(8):1807\u201312.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"634_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13195-017-0322-2","volume":"9","author":"SM Jeong","year":"2017","unstructured":"Jeong SM, Shin DW, Lee JE, Hyeon JH, Lee J, Kim S. Anemia is associated with incidence of dementia: a national health screening study in Korea involving 37,900 persons. Alzheimers Res Ther. 2017;9(1):94.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"634_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13195-018-0440-5","volume":"10","author":"B Tan","year":"2018","unstructured":"Tan B, Venketasubramanian N, Vrooman H, Cheng CY, Wong TY, Chen C, Hilal S. Haemoglobin, magnetic resonance imaging markers and cognition: a subsample of population-based study. Alzheimers Res Ther. 2018;10(1):114.","journal-title":"Alzheimers Res Ther"},{"issue":"36","key":"634_CR14","doi-asserted-by":"publisher","first-page":"15454","DOI":"10.1073\/pnas.0813216106","volume":"106","author":"M Biagioli","year":"2009","unstructured":"Biagioli M, Pinto M, Cesselli D, Zaninello M, Lazarevic D, Roncaglia P, Simone R, Vlachouli C, Plessy C, Bertin N, et al. Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci U S A. 2009;106(36):15454\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"634_CR15","doi-asserted-by":"publisher","first-page":"110680","DOI":"10.1016\/j.exger.2019.110680","volume":"126","author":"MA Altinoz","year":"2019","unstructured":"Altinoz MA, Guloksuz S, Schmidt-Kastner R, Kenis G, Ince B, Rutten BPF. Involvement of hemoglobins in the pathophysiology of Alzheimer\u2019s disease. Exp Gerontol. 2019;126:110680.","journal-title":"Exp Gerontol"},{"issue":"5","key":"634_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/cne.22062","volume":"515","author":"F Richter","year":"2009","unstructured":"Richter F, Meurers BH, Zhu C, Medvedeva VP, Chesselet MF. Neurons express hemoglobin alpha- and beta-chains in rat and human brains. J Comp Neurol. 2009;515(5):538\u201347.","journal-title":"J Comp Neurol"},{"issue":"9","key":"634_CR17","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1523\/JNEUROSCI.23-09-03807.2003","volume":"23","author":"EM Blalock","year":"2003","unstructured":"Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC, Landfield PW. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci. 2003;23(9):3807\u201319.","journal-title":"J Neurosci"},{"issue":"3","key":"634_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033120","volume":"7","author":"JY Chuang","year":"2012","unstructured":"Chuang JY, Lee CW, Shih YH, Yang T, Yu L, Kuo YM. Interactions between amyloid-beta and hemoglobin: implications for amyloid plaque formation in Alzheimer\u2019s disease. PLoS One. 2012;7(3):e33120.","journal-title":"PLoS One"},{"issue":"3","key":"634_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.nbd.2004.08.014","volume":"17","author":"CW Wu","year":"2004","unstructured":"Wu CW, Liao PC, Yu L, Wang ST, Chen ST, Wu CM, Kuo YM. Hemoglobin promotes Abeta oligomer formation and localizes in neurons and amyloid deposits. Neurobiol Dis. 2004;17(3):367\u201377.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"634_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0925-4439(02)00213-2","volume":"1637","author":"N Masuoka","year":"2003","unstructured":"Masuoka N, Kodama H, Abe T, Wang DH, Nakano T. Characterization of hydrogen peroxide removal reaction by hemoglobin in the presence of reduced pyridine nucleotides. Biochim Biophys Acta. 2003;1637(1):46\u201354.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"634_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/jcbfm.2008.152","volume":"29","author":"DW Schelshorn","year":"2009","unstructured":"Schelshorn DW, Schneider A, Kuschinsky W, Weber D, Kruger C, Dittgen T, Burgers HF, Sabouri F, Gassler N, Bach A, et al. Expression of hemoglobin in rodent neurons. J Cereb Blood Flow Metab. 2009;29(3):585\u201395.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"634_CR22","first-page":"118","volume":"49","author":"H Yang","year":"2011","unstructured":"Yang H, Qiao H, Tian X. Proteomic analysis of cerebral synaptosomes isolated from rat model of Alzheimer\u2019s disease. Indian J Exp Biol. 2011;49(2):118\u201324.","journal-title":"Indian J Exp Biol"},{"issue":"1","key":"634_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12031-015-0711-6","volume":"59","author":"N Brown","year":"2016","unstructured":"Brown N, Alkhayer K, Clements R, Singhal N, Gregory R, Azzam S, Li S, Freeman E, McDonough J. Neuronal hemoglobin expression and its relevance to multiple sclerosis neuropathology. J Mol Neurosci. 2016;59(1):1\u201317.","journal-title":"J Mol Neurosci"},{"issue":"7424","key":"634_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nature11626","volume":"491","author":"AC Straub","year":"2012","unstructured":"Straub AC, Lohman AW, Billaud M, Johnstone SR, Dwyer ST, Lee MY, Bortz PS, Best AK, Columbus L, Gaston B, et al. Endothelial cell expression of haemoglobin alpha regulates nitric oxide signalling. Nature. 2012;491(7424):473\u20137.","journal-title":"Nature"},{"issue":"3","key":"634_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/JAD-2010-101485","volume":"23","author":"I Ferrer","year":"2011","unstructured":"Ferrer I, Gomez A, Carmona M, Huesa G, Porta S, Riera-Codina M, Biagioli M, Gustincich S, Aso E. Neuronal hemoglobin is reduced in Alzheimer\u2019s disease, argyrophilic grain disease, Parkinson\u2019s disease, and dementia with Lewy bodies. J Alzheimers Dis. 2011;23(3):537\u201350.","journal-title":"J Alzheimers Dis"},{"issue":"7\u20138","key":"634_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/prca.201400178","volume":"9","author":"DS Spellman","year":"2015","unstructured":"Spellman DS, Wildsmith KR, Honigberg LA, Tuefferd M, Baker D, Raghavan N, Nairn AC, Croteau P, Schirm M, Allard R, et al. Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer\u2019s disease neuroimaging initiative (ADNI) CSF. Proteomics Clin Appl. 2015;9(7\u20138):715\u201331.","journal-title":"Proteomics Clin Appl"},{"issue":"2","key":"634_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.taap.2004.06.021","volume":"202","author":"G Papanikolaou","year":"2005","unstructured":"Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005;202(2):199\u2013211.","journal-title":"Toxicol Appl Pharmacol"},{"key":"634_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fphys.2015.00187","volume":"6","author":"A Smith","year":"2015","unstructured":"Smith A, McCulloh RJ. Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders. Front Physiol. 2015;6:187.","journal-title":"Front Physiol"},{"issue":"4","key":"634_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/104454902753759717","volume":"21","author":"E Tolosano","year":"2002","unstructured":"Tolosano E, Altruda F. Hemopexin: structure, function, and regulation. DNA Cell Biol. 2002;21(4):297\u2013306.","journal-title":"DNA Cell Biol"},{"issue":"2","key":"634_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1179\/016164106X98035","volume":"28","author":"EM Castano","year":"2006","unstructured":"Castano EM, Roher AE, Esh CL, Kokjohn TA, Beach T. Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer\u2019s disease and non-demented elderly subjects. Neurol Res. 2006;28(2):155\u201363.","journal-title":"Neurol Res"},{"issue":"22","key":"634_CR31","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/rcm.834","volume":"16","author":"P Davidsson","year":"2002","unstructured":"Davidsson P, Folkesson S, Christiansson M, Lindbjer M, Dellheden B, Blennow K, Westman-Brinkmalm A. Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption\/ionisation mass spectrometry. Rapid Commun Mass Spectrom. 2002;16(22):2083\u20138.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"4","key":"634_CR32","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3171\/2010.10.JNS10861","volume":"114","author":"L Chen","year":"2011","unstructured":"Chen L, Zhang X, Chen-Roetling J, Regan RF. Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice. J Neurosurg. 2011;114(4):1159\u201367.","journal-title":"J Neurosurg"},{"key":"634_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12974-016-0490-1","volume":"13","author":"B Ma","year":"2016","unstructured":"Ma B, Day JP, Phillips H, Slootsky B, Tolosano E, Dore S. Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage. J Neuroinflammation. 2016;13:26.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"634_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/jnc.12165","volume":"125","author":"P Hahl","year":"2013","unstructured":"Hahl P, Davis T, Washburn C, Rogers JT, Smith A. Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states. J Neurochem. 2013;125(1):89\u2013101.","journal-title":"J Neurochem"},{"issue":"3","key":"634_CR35","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3233\/JAD-171145","volume":"62","author":"RN Martins","year":"2018","unstructured":"Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, et al. Alzheimer\u2019s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies-gains from AIBL and DIAN cohort studies. J Alzheimers Dis. 2018;62(3):965\u201392.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"634_CR36","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1017\/S1041610209009405","volume":"21","author":"KA Ellis","year":"2009","unstructured":"Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer\u2019s disease. Int Psychogeriatr. 2009;21(4):672\u201387.","journal-title":"Int Psychogeriatr"},{"issue":"8","key":"634_CR37","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","volume":"31","author":"CC Rowe","year":"2010","unstructured":"Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging. 2010;31(8):1275\u201383.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"634_CR38","doi-asserted-by":"publisher","first-page":"eaau7220","DOI":"10.1126\/sciadv.aau7220","volume":"5","author":"NJ Ashton","year":"2019","unstructured":"Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, Goozee K, Hone E, Pedrini S, Blennow K, et al. A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer\u2019s disease. Sci Adv. 2019;5(2):eaau7220.","journal-title":"Sci Adv"},{"issue":"4","key":"634_CR39","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"634_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303\u20138.","journal-title":"Arch Neurol"},{"issue":"3","key":"634_CR41","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","volume":"256","author":"B Winblad","year":"2004","unstructured":"Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240\u20136.","journal-title":"J Intern Med"},{"issue":"7","key":"634_CR42","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34(7):939\u201344.","journal-title":"Neurology"},{"issue":"11","key":"634_CR43","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134.","journal-title":"Neurology"},{"key":"634_CR44","unstructured":"American Psychiatric A, Task Force on D-I, Frances AA, Pincus HA, First MB: Diagnostic and statistical manual of mental disorders. DMS-IV. DMS-IV. Washington: American Psychiatric Association; 1994."},{"key":"634_CR45","volume-title":"The ICD-10 classification of mental and behavioural disorders : diagnostic criteria for research","author":"World Health O","year":"2003","unstructured":"World Health O. The ICD-10 classification of mental and behavioural disorders : diagnostic criteria for research. Geneva: World Health Organization; 2003."},{"issue":"1","key":"634_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/107327481001700108","volume":"17","author":"JJ Chen","year":"2010","unstructured":"Chen JJ, Roberson PK, Schell MJ. The false discovery rate: a key concept in large-scale genetic studies. Cancer Control. 2010;17(1):58\u201362.","journal-title":"Cancer Control"},{"key":"634_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nbd.2015.08.007","volume":"81","author":"DG Peters","year":"2015","unstructured":"Peters DG, Connor JR, Meadowcroft MD. The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer\u2019s disease: two sides of the same coin. Neurobiol Dis. 2015;81:49\u201365.","journal-title":"Neurobiol Dis"},{"issue":"30","key":"634_CR48","doi-asserted-by":"publisher","first-page":"11153","DOI":"10.1073\/pnas.0404349101","volume":"101","author":"H Atamna","year":"2004","unstructured":"Atamna H, Frey WH 2nd. A role for heme in Alzheimer\u2019s disease: heme binds amyloid beta and has altered metabolism. Proc Natl Acad Sci U S A. 2004;101(30):11153\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"634_CR49","doi-asserted-by":"publisher","first-page":"11358","DOI":"10.1074\/jbc.RA117.001050","volume":"293","author":"SB Sankar","year":"2018","unstructured":"Sankar SB, Donegan RK, Shah KJ, Reddi AR, Wood LB. Heme and hemoglobin suppress amyloid beta-mediated inflammatory activation of mouse astrocytes. J Biol Chem. 2018;293(29):11358\u201373.","journal-title":"J Biol Chem"},{"issue":"8","key":"634_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023789","volume":"6","author":"KE Biron","year":"2011","unstructured":"Biron KE, Dickstein DL, Gopaul R, Jefferies WA. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer\u2019s disease. PLoS One. 2011;6(8):e23789.","journal-title":"PLoS One"},{"issue":"9","key":"634_CR51","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1073\/pnas.0600134103","volume":"103","author":"H Atamna","year":"2006","unstructured":"Atamna H, Boyle K. Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2006;103(9):3381\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"634_CR52","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.4103\/1673-5374.235021","volume":"13","author":"J Flemmig","year":"2018","unstructured":"Flemmig J, Zamocky M, Alia A. Amyloid beta and free heme: bloody new insights into the pathogenesis of Alzheimer\u2019s disease. Neural Regen Res. 2018;13(7):1170\u20134.","journal-title":"Neural Regen Res"},{"issue":"1","key":"634_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1021\/ja1084578","volume":"133","author":"D Pramanik","year":"2011","unstructured":"Pramanik D, Dey SG. Active site environment of heme-bound amyloid beta peptide associated with Alzheimer\u2019s disease. J Am Chem Soc. 2011;133(1):81\u20137.","journal-title":"J Am Chem Soc"},{"issue":"3","key":"634_CR54","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.bbrc.2014.08.130","volume":"452","author":"N Lu","year":"2014","unstructured":"Lu N, Li J, Tian R, Peng YY. Key roles of Arg(5), Tyr(10) and his residues in Abeta-heme peroxidase: relevance to Alzheimer\u2019s disease. Biochem Biophys Res Commun. 2014;452(3):676\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"634_CR55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/2051-5960-1-83","volume":"1","author":"YK Al-Hilaly","year":"2013","unstructured":"Al-Hilaly YK, Williams TL, Stewart-Parker M, Ford L, Skaria E, Cole M, Bucher WG, Morris KL, Sada AA, Thorpe JR, et al. A central role for dityrosine crosslinking of amyloid-beta in Alzheimer\u2019s disease. Acta Neuropathol Commun. 2013;1:83.","journal-title":"Acta Neuropathol Commun"},{"issue":"36","key":"634_CR56","doi-asserted-by":"publisher","first-page":"14343","DOI":"10.1039\/C6DT02183B","volume":"45","author":"V Pirota","year":"2016","unstructured":"Pirota V, Monzani E, Dell'Acqua S, Casella L. Interactions between heme and tau-derived R1 peptides: binding and oxidative reactivity. Dalton Trans. 2016;45(36):14343\u201351.","journal-title":"Dalton Trans"},{"issue":"33","key":"634_CR57","doi-asserted-by":"publisher","first-page":"13658","DOI":"10.1074\/jbc.M117.783951","volume":"292","author":"P Hahl","year":"2017","unstructured":"Hahl P, Hunt R, Bjes ES, Skaff A, Keightley A, Smith A. Identification of oxidative modifications of hemopexin and their predicted physiological relevance. J Biol Chem. 2017;292(33):13658\u201371.","journal-title":"J Biol Chem"},{"issue":"11","key":"634_CR58","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/pmic.200300475","volume":"3","author":"HL Yu","year":"2003","unstructured":"Yu HL, Chertkow HM, Bergman H, Schipper HM. Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma. Proteomics. 2003;3(11):2240\u20138.","journal-title":"Proteomics"},{"issue":"7","key":"634_CR59","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1182\/blood-2005-03-1185","volume":"106","author":"V Hvidberg","year":"2005","unstructured":"Hvidberg V, Maniecki MB, Jacobsen C, Hojrup P, Moller HJ, Moestrup SK. Identification of the receptor scavenging hemopexin-heme complexes. Blood. 2005;106(7):2572\u20139.","journal-title":"Blood"},{"issue":"11","key":"634_CR60","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood-2008-08-174466","volume":"113","author":"PW Buehler","year":"2009","unstructured":"Buehler PW, Abraham B, Vallelian F, Linnemayr C, Pereira CP, Cipollo JF, Jia Y, Mikolajczyk M, Boretti FS, Schoedon G, et al. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood. 2009;113(11):2578\u201386.","journal-title":"Blood"},{"issue":"10","key":"634_CR61","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.freeradbiomed.2012.08.596","volume":"53","author":"A Cocciolo","year":"2012","unstructured":"Cocciolo A, Di Domenico F, Coccia R, Fiorini A, Cai J, Pierce WM, Mecocci P, Butterfield DA, Perluigi M. Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: insights from redox proteomics. Free Radic Biol Med. 2012;53(10):1868\u201376.","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"634_CR62","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1096\/fj.06-7986com","volume":"21","author":"JJ Yerbury","year":"2007","unstructured":"Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM, Wilson MR. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J. 2007;21(10):2312\u201322.","journal-title":"FASEB J"},{"key":"634_CR63","doi-asserted-by":"publisher","unstructured":"Ayton S, Wang Y, Diouf I, Schneider JA, Brockman J, Morris MC, Bush AI: Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology. Mol Psychiatry 2019. https:\/\/doi.org\/10.1038\/s41380-019-0375-7.","DOI":"10.1038\/s41380-019-0375-7"},{"issue":"1","key":"634_CR64","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000330467","volume":"1","author":"G Torsdottir","year":"2011","unstructured":"Torsdottir G, Kristinsson J, Snaedal J, Johannesson T. Ceruloplasmin and iron proteins in the serum of patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Dis Extra. 2011;1(1):366\u201371.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"4","key":"634_CR65","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"634_CR66","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain. 2018;141(7):2181\u201393.","journal-title":"Brain"},{"issue":"5","key":"634_CR67","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1046\/j.1471-4159.2002.t01-1-01061.x","volume":"82","author":"A Yamamoto","year":"2002","unstructured":"Yamamoto A, Shin RW, Hasegawa K, Naiki H, Sato H, Yoshimasu F, Kitamoto T. Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer\u2019s disease. J Neurochem. 2002;82(5):1137\u201347.","journal-title":"J Neurochem"},{"issue":"1","key":"634_CR68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/jnc.14312","volume":"145","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Chen X, Huang S, Li G, Mo M, Zhang L, Chen C, Guo W, Zhou M, Wu Z, et al. Iron promotes alpha-synuclein aggregation and transmission by inhibiting TFEB-mediated autophagosome-lysosome fusion. J Neurochem. 2018;145(1):34\u201350.","journal-title":"J Neurochem"},{"key":"634_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fnins.2019.00015","volume":"13","author":"K Joppe","year":"2019","unstructured":"Joppe K, Roser AE, Maass F, Lingor P. The contribution of iron to protein aggregation disorders in the central nervous system. Front Neurosci. 2019;13:15.","journal-title":"Front Neurosci"},{"issue":"3","key":"634_CR70","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1523\/JNEUROSCI.5443-08.2009","volume":"29","author":"SY Jeong","year":"2009","unstructured":"Jeong SY, Rathore KI, Schulz K, Ponka P, Arosio P, David S. Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci. 2009;29(3):610\u20139.","journal-title":"J Neurosci"},{"key":"634_CR71","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.redox.2020.101494","volume":"32","author":"A Ashraf","year":"2020","unstructured":"Ashraf A, Jeandriens J, Parkes HG, So PW. Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine\/glutamate antiporter in Alzheimer\u2019s disease: evidence of ferroptosis. Redox Biol. 2020;32:101494.","journal-title":"Redox Biol"},{"issue":"8","key":"634_CR72","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1093\/brain\/awx137","volume":"140","author":"S Ayton","year":"2017","unstructured":"Ayton S, Fazlollahi A, Bourgeat P, Raniga P, Ng A, Lim YY, Diouf I, Farquharson S, Fripp J, Ames D, et al. Cerebral quantitative susceptibility mapping predicts amyloid-beta-related cognitive decline. Brain. 2017;140(8):2112\u20139.","journal-title":"Brain"},{"issue":"7","key":"634_CR73","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1021\/acschemneuro.8b00194","volume":"9","author":"L Du","year":"2018","unstructured":"Du L, Zhao Z, Cui A, Zhu Y, Zhang L, Liu J, Shi S, Fu C, Han X, Gao W, et al. Increased iron deposition on brain quantitative susceptibility mapping correlates with decreased cognitive function in Alzheimer\u2019s disease. ACS Chem Neurosci. 2018;9(7):1849\u201357.","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"634_CR74","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3233\/JAD-140396","volume":"42","author":"Y Tao","year":"2014","unstructured":"Tao Y, Wang Y, Rogers JT, Wang F. Perturbed iron distribution in Alzheimer\u2019s disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis. J Alzheimers Dis. 2014;42(2):679\u201390.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"634_CR75","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/jmri.21730","volume":"29","author":"B Ding","year":"2009","unstructured":"Ding B, Chen KM, Ling HW, Sun F, Li X, Wan T, Chai WM, Zhang H, Zhan Y, Guan YJ. Correlation of iron in the hippocampus with MMSE in patients with Alzheimer\u2019s disease. J Magn Reson Imaging. 2009;29(4):793\u20138.","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"634_CR76","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/0006-3223(94)90047-7","volume":"35","author":"G Bartzokis","year":"1994","unstructured":"Bartzokis G, Sultzer D, Mintz J, Holt LE, Marx P, Phelan CK, Marder SR. In vivo evaluation of brain iron in Alzheimer\u2019s disease and normal subjects using MRI. Biol Psychiatry. 1994;35(7):480\u20137.","journal-title":"Biol Psychiatry"},{"issue":"9","key":"634_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076203","volume":"8","author":"Z Luo","year":"2013","unstructured":"Luo Z, Zhuang X, Kumar D, Wu X, Yue C, Han C, Lv J. The correlation of hippocampal T2-mapping with neuropsychology test in patients with Alzheimer\u2019s disease. PLoS One. 2013;8(9):e76203.","journal-title":"PLoS One"},{"key":"634_CR78","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","volume":"133","author":"S Masaldan","year":"2019","unstructured":"Masaldan S, Bush AI, Devos D, Rolland AS, Moreau C. Striking while the iron is hot: iron metabolism and ferroptosis in neurodegeneration. Free Radic Biol Med. 2019;133:221\u201333.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"634_CR79","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neurobiolaging.2005.01.016","volume":"27","author":"HM Schipper","year":"2006","unstructured":"Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J, Arvanitakis Z. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging. 2006;27(2):252\u201361.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"634_CR80","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3233\/JAD-140567","volume":"43","author":"D Wang","year":"2015","unstructured":"Wang D, Hui Y, Peng Y, Tang L, Jin J, He R, Li Y, Zhang S, Li L, Zhou Y, et al. Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice. J Alzheimers Dis. 2015;43(2):519\u201334.","journal-title":"J Alzheimers Dis"},{"key":"634_CR81","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroscience.2016.07.003","volume":"332","author":"J Sripetchwandee","year":"2016","unstructured":"Sripetchwandee J, Wongjaikam S, Krintratun W, Chattipakorn N, Chattipakorn SC. A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-beta accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload. Neuroscience. 2016;332:191\u2013202.","journal-title":"Neuroscience"},{"issue":"4","key":"634_CR82","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1523\/JNEUROSCI.14-04-02225.1994","volume":"14","author":"JR Slemmon","year":"1994","unstructured":"Slemmon JR, Hughes CM, Campbell GA, Flood DG. Increased levels of hemoglobin-derived and other peptides in Alzheimer\u2019s disease cerebellum. J Neurosci. 1994;14(4):2225\u201335.","journal-title":"J Neurosci"},{"issue":"1","key":"634_CR83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0197-4580(91)90033-G","volume":"12","author":"GJ Bosman","year":"1991","unstructured":"Bosman GJ, Bartholomeus IG, de Man AJ, van Kalmthout PJ, de Grip WJ. Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer\u2019s disease. Neurobiol Aging. 1991;12(1):13\u20138.","journal-title":"Neurobiol Aging"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00634-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00634-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00634-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T19:36:21Z","timestamp":1623180981000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00634-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["634"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00634-1","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"5 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AIBL and KARVIAH were approved by the institutional review board and ethics committees of participating institutions, and written informed consent was obtained from all participants or their next of kin.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consented manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}